Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
9.24 Up 0.98(11.86%) Sep 2, 3:59PM EDT
|Pre-Market : 9.30 Up 0.07 (0.76%) 8:55AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:8.26
Open:8.40
Bid:9.15 x 2500
Ask:9.30 x 1000
1y Target Est:27.80
Beta:1.6303
Earnings Date:Nov 3 - Nov 9 (Est.)
Day's Range:8.23 - 9.25
52wk Range:6.23 - 25.60
Volume:1,074,790
Avg Vol (3m):818,143
Market Cap:479.74M
P/E (ttm):N/A
EPS (ttm):-1.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.35
Quarterly EPS Est (Sep-15) :-0.37
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback